we are a company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with a technology-based healthcare business domiciled in israel, or that carries out a substantial portion of its activities in israel, or that has some other significant israeli connection
Company profile
Ticker
CCTS
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
981598362
CCTS stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
11 Mar 24
8-K
Entry into a Material Definitive Agreement
23 Feb 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
2 Nov 23
DEFA14A
Additional proxy soliciting materials
1 Nov 23
8-K
Cactus Acquisition Corp. 1 Limited Announces Contributions to Trust Account In Connection with Proposed Extension
30 Oct 23
DEFA14A
Additional proxy soliciting materials
27 Oct 23
8-K
Entry into a Material Definitive Agreement
27 Oct 23
DEF 14A
Definitive proxy
27 Oct 23
8-K
Other Events
24 Oct 23
Latest ownership filings
3
Joseph Cornelius Thomassen
6 Mar 24
3
Huiyan Geng
6 Mar 24
3
Initial statement of insider ownership
6 Mar 24
3
Emmanuel Meyer
6 Mar 24
3
Pirone Rafael Meyer
6 Mar 24
SC 13D
EVGI Ltd
6 Mar 24
4
Change in insider ownership
27 Feb 24
SC 13G
683 Capital Management, LLC
14 Feb 24
SC 13G
RIVERNORTH CAPITAL MANAGEMENT, LLC
14 Feb 24
SC 13G/A
Radcliffe Capital Management, L.P.
14 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.63 k | 24.63 k | 24.63 k | 24.63 k | 24.63 k | 24.63 k |
Cash burn (monthly) | 8.10 mm | 8.80 k | 56.33 | 147.46 k | 612.35 k | (no burn) |
Cash used (since last report) | 48.47 mm | 52.68 k | 337.10 | 882.39 k | 3.66 mm | n/a |
Cash remaining | -48.44 mm | -28.05 k | 24.29 k | -857.76 k | -3.64 mm | n/a |
Runway (months of cash) | -6.0 | -3.2 | 431.1 | -5.8 | -5.9 | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 35 |
Opened positions | 2 |
Closed positions | 7 |
Increased positions | 1 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 5.64 bn |
Total shares | 7.84 mm |
Total puts | 0.00 |
Total calls | 61.50 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Cactus Healthcare Management | 3.16 mm | $0.00 |
Periscope Capital | 833.46 k | $32.71 mm |
Mangrove Partners | 499.60 k | $5.51 bn |
Calamos Advisors | 375.00 k | $15.99 mm |
Saba Capital Management | 273.00 k | $11.64 mm |
Shaolin Capital Management | 258.58 k | $6.00 k |
Sculptor Capital | 250.00 k | $10.66 mm |
683 Capital Management | 225.00 k | $5.65 mm |
Context Capital Management | 215.35 k | $5.00 k |
Cubist Systematic Strategies | 201.78 k | $5.07 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Feb 24 | Cactus Healthcare Management | Class A ordinary shares | Sell | Dispose S | No | No | 0 | 2,530,000 | 0.00 | 632,501 |
23 Feb 24 | Cactus Healthcare Management | Warrants to purchase Class A ordinary shares Class A ordinary shares | Sell | Dispose S | No | No | 11.5 | 3,893,334 | 44.77 mm | 973,333 |